Total amount raised
$177 Millions
Latest funding date
07/01/2024
Location
Thyme Care has successfully raised $95 million in its latest Series C funding round, with strategic investments from Echo Health Ventures and CVS Health Ventures. The company specializes in oncology care management, offering personalized cancer care navigation and clinical support.
Keep reading to explore the intricacies of Thyme Care's fundraising journey and the investors backing this innovative platform.
What Is Thyme Care?
Thyme Care, founded in 2020 by Bobby Green and Robin Shah, is based in Nashville, Tennessee. The company specializes in oncology care management, offering personalized cancer care navigation and clinical support. With a team of 101-250 employees, Thyme Care aims to revolutionize cancer care by providing holistic and integrated solutions for patients and healthcare providers.
How Much Funding Has Thyme Care Raised?
- Series A
- Amount Raised: $22M
- Date: October 2021
- Lead Investors: AlleyCorp, Andreessen Horowitz, Frist Cressey Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To establish a strong foundation for their oncology care management services and expand their initial market presence.
- Series B
- Amount Raised: $60M
- Date: August 2023
- Lead Investors: Foresite Capital, Town Hall Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale their operations and enhance their technology platform for better patient outcomes.
- Venture Round
- Amount Raised: Not disclosed
- Date: May 2024
- Lead Investors: CVS Health Ventures, Echo Health Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate partnerships and expand their cancer care navigation services.
- Series C
- Amount Raised: $55M
- Date: July 2024
- Lead Investors: Concord Health Partners
- Valuation at Round: $480M
- Motivation Behind the Round: To expand cancer care navigation to new markets and accelerate partnerships.
- Debt Financing
- Amount Raised: $40M
- Date: July 2024
- Lead Investors: Banc of California
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's growth and operational expansion.
Total Amount Raised: $177M
Current Valuation: $480M
Key Investors
- Concord Health Partners
- Details: Concord Health Partners is a healthcare-focused investment firm that led Thyme Care's Series C funding round.
- Investment Focus Areas: Healthcare innovation, healthcare services.
- Notable Investments: Specific notable investments are not mentioned.
- CVS Health Ventures
- Details: CVS Health Ventures is the venture capital arm of CVS Health, focusing on healthcare innovation. They participated as an existing investor in Thyme Care's Series C funding round.
- Investment Focus Areas: Healthcare innovation, health technology.
- Notable Investments: Specific notable investments are not mentioned.
- Echo Health Ventures
- Details: Echo Health Ventures is a strategic collaboration between Cambia Health Solutions and Mosaic Health Solutions, investing in healthcare companies. They participated as an existing investor in Thyme Care's Series C funding round.
- Investment Focus Areas: Healthcare services, healthcare technology.
- Notable Investments: Specific notable investments are not mentioned.
- Foresite Capital
- Details: Foresite Capital is a multi-stage healthcare and life sciences investment firm. They participated as an existing investor in Thyme Care's Series C funding round.
- Investment Focus Areas: Healthcare, life sciences.
- Notable Investments: Specific notable investments are not mentioned.
- Town Hall Ventures
- Details: Town Hall Ventures is an investment firm focused on healthcare companies serving vulnerable populations. They participated as an existing investor in Thyme Care's Series C funding round.
- Investment Focus Areas: Healthcare for vulnerable populations.
- Notable Investments: Specific notable investments are not mentioned.
What's Next for Thyme Care?
Thyme Care stands at the cusp of significant growth opportunities, driven by its recent $480 million valuation. The company is poised to expand its services, leveraging partnerships with health plans, employers, and over 800 oncologists to enhance cancer care quality and reduce costs. This expansion into new markets and investment in technology-enabled care teams positions Thyme Care for substantial growth.
Future fundraising opportunities appear promising, given the strong investor interest and substantial funds already raised. The company is likely to attract further investment to support its scaling efforts and technological advancements. However, challenges such as navigating regulatory requirements, managing scalability, and facing competition from other value-based care providers remain. Despite these hurdles, Thyme Care's innovative approach and robust financial backing suggest a bright future ahead.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Thyme Care and gather other critical business insights.
Sign up for free and start exploring the wealth of information available at Clay's signup page.
